Overcoming Resistance to EGFR Neutralization by Combination of Monoclonal Antibodies and Novel Cancer Drugs
NCT06863818
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna